Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -32.24% is 47% above its 5-year average of -60.78%, near the high end of its 5-year range (-250.62%–-22.32%).
As of the fiscal period ended Tuesday, June 30, 2026. 76.17% above its 12-month average of -135.28%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -32.24%.
RETURN ON INVESTED CAPITAL (ROIC)
-32.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-135.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-80.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-60.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+76.17%
CURRENT VS 3Y AVG
+60.05%
CURRENT VS 5Y AVG
+46.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+9.60%
vs the sector median at left
Vor Biopharma Inc.
Market Cap
$992.14M
Return on Invested Capital (ROIC)
-32.24%
TTM Avg
-135.28%
3Y Avg
-80.70%
5Y Avg
-60.78%
Market Cap
$996.65M
Return on Invested Capital (ROIC)
-27.51%
TTM Avg
-21.69%
3Y Avg
-25.73%
5Y Avg
-26.71%
Market Cap
$998.69M
Return on Invested Capital (ROIC)
-68.64%
TTM Avg
-46.08%
3Y Avg
-28.67%
5Y Avg
-26.80%
Market Cap
$982.46M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-132.46%
3Y Avg
-76.17%
5Y Avg
-76.17%
Market Cap
$981.66M
Return on Invested Capital (ROIC)
52.81%
TTM Avg
-75.45%
3Y Avg
-63.24%
5Y Avg
-50.31%
Market Cap
$1.01B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
Market Cap
$978.09M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$973.93M
Return on Invested Capital (ROIC)
1.35%
TTM Avg
-1.75%
3Y Avg
1.09%
5Y Avg
1.96%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-3.44%
3Y Avg
-10.34%
5Y Avg
-8.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vor Biopharma Inc. (VOR) | $992.14M | -32.24% | -135.28% | -80.70% | -60.78% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -27.51% | -21.69% | -25.73% | -26.71% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -68.64% | -46.08% | -28.67% | -26.80% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | -28.14% | -132.46% | -76.17% | -76.17% |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | 52.81% | -75.45% | -63.24% | -50.31% |
| Immatics N.V. (IMTX)vs › | $1.01B | -53.36% | -19.72% | -15.42% | -34.93% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 1.35% | -1.75% | 1.09% | 1.96% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | -6.33% | -3.44% | -10.34% | -8.68% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | -15.15% | -12.74% | -16.16% | -18.46% |
ROIC
-32.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -32.24% |
| 2026-03-31 | -76.12% |
| 2025-12-31 | -84.61% |
| 2025-09-30 | -232.79% |
| 2025-06-30 | -250.62% |
| 2025-03-31 | -131.93% |
| 2024-12-31 | -97.51% |
| 2024-09-30 | -116.09% |
| 2024-06-30 | -97.66% |
| 2024-03-31 | -83.18% |
| 2023-12-31 | -63.63% |
| 2023-09-30 | -58.02% |
| 2023-06-30 | -46.76% |
| 2023-03-31 | -37.61% |
| 2022-12-31 | -32.64% |
| 2022-09-30 | -44.55% |
| 2022-06-30 | -37.60% |
| 2022-03-31 | -36.13% |
| 2021-12-31 | -29.69% |
| 2021-09-30 | -26.61% |
| 2021-06-30 | -22.32% |
| 2021-03-31 | -17.24% |
| 2020-12-31 | -65.15% |
| 2020-09-30 | -38.75% |
| 2020-06-30 | -25.54% |
| 2019-12-31 | -136.35% |
